Summary by Futu AI
60 Degrees Pharmaceuticals, Inc. (60P) has announced the scheduling of its 2024 Annual Meeting of Stockholders to be conducted virtually on July 16, 2024. The meeting will be accessible via live audio webcast, with no option for in-person attendance. Stockholders are invited to attend, register, obtain proxy materials, submit questions, and vote at the meeting. The company plans to make proxy materials available on or about June 6, 2024, primarily over the internet, to expedite delivery, reduce costs, and conserve resources. The meeting agenda includes the election of five directors, approval of an amendment to increase authorized shares under the 2022 Equity Incentive Plan, approval of a reverse stock split, modifications to the strike price of options for the CEO and CFO, issuance of options to a consultant, and the ratification of RBSM LLP as the independent auditor for the fiscal year ending December 31, 2024. The board recommends voting 'FOR' all proposals. The company emphasizes the importance of stockholder votes, regardless of attendance at the Annual Meeting.